Mirikizumab improves fatigue, bowel urgency, and quality of life in patients with moderately to severely active Crohn's Disease: Results from a phase 3 clinical trial
JOURNAL OF CROHNS & COLITIS(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要